According to Acorda Therapeutics 's latest financial reports the company's current EPS (TTM) is -$9.78. In 2022 the company made an earnings per share (EPS) of -$88.20 an increase over its 2021 EPS that were of -$199.60.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$9.78 | -88.91% |
2022 | -$88.20 | -55.81% |
2021 | -$199.60 | -16.13% |
2020 | -$238.00 | -65.51% |
2019 | -$690.00 | -898.61% |
2018 | $86.40 | -114.88% |
2017 | -$580.80 | 536.84% |
2016 | -$91.20 | -392.31% |
2015 | $31.20 | -39.53% |
2014 | $51.60 | 4.88% |
2013 | $49.20 | -89.54% |
2012 | $470.40 | 409.09% |
2011 | $92.40 | -333.33% |
2010 | -$39.60 | -85.14% |
2009 | -$266.40 | 1.37% |
2008 | -$262.80 | 51.03% |
2007 | -$174.00 | -68.27% |
2006 | -$548.40 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Sarepta Therapeutics
SRPT | -$7.83 | -19.92% | ๐บ๐ธ USA |
Repligen
RGEN | $2.09 | -121.38% | ๐บ๐ธ USA |
Affimed
AFMD | -$0.79 | -91.92% | ๐ฉ๐ช Germany |
BioMarin Pharmaceutical BMRN | $0.78 | -107.96% | ๐บ๐ธ USA |